Position in AMRX
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$295,308
+$219,373 QoQ
Shares Held
17,060
-6.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#21
of 56 holders
Holding Since
Mar 2021
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Diversified Trust Co holds $7,361,298 across 10 Drug Manufacturers - Specialty & Generic names. AMRX ranks #6 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
54,538 | $2,857,518 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
2,216 | $1,200,695 | |
| 3 | VTRS |
Viatris Inc
|
56,808 | $902,111 | |
| 4 | ZTS |
Zoetis Inc.
|
9,027 | $648,680 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
3,838 | $646,856 | |
| 6 | AMRX |
Amneal Pharmaceuticals, Inc.
This page
|
17,060 | $295,308 | |
| 7 | HLN |
Haleon plc
|
30,794 | $287,308 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
|
32,062 | $253,931 |
All Filings in AMRX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $295,308 | 17,060 | Shares | Sole | 2026-07-17 | |
| 2022-03-31 | $75,935 | 18,210 | Shares | Sole | 2022-04-07 | |
| 2021-12-31 | $112,177 | 23,419 | Shares | Sole | 2022-01-13 | |
| 2021-09-30 | $125,057 | 23,419 | Shares | Sole | 2022-01-13 | |
| 2021-06-30 | $188,948 | 36,904 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $139,553 | 20,736 | Shares | Sole | 2021-05-10 | |
| No filing history on record for this holder in this stock. | ||||||